Live feed
Filing
SC 13G/A
SC 13G/A0000921895-24-002625·4D Molecular Therapeutics, Inc.
Schedule 13G ownership disclosure
4D Molecular Therapeutics Inc
Security class unavailable · CUSIP: 35104E100
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-24-002625
- Form type
- SC 13G/A
- Filer
- 4D Molecular Therapeutics, Inc.
- CIK
- CIK 1650648
- Filed
- Nov 13, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership